Medindia

X

First Responders Acquire Revolutionary MyClyns(TM) Protective Spray

Tuesday, February 12, 2008 General News J E 4
Advertisement
UNION, Ky., Feb. 11 Union Springs Pharmaceuticals, LLC,announced today that its revolutionary new product for use after a potentialpathogenic exposure, MyClyns(TM), is available for shipment to customers. Thecompany has also upgraded its web site, added a customer service center anddeployed regional product specialists to support the MyClyns release.

Orders can now be placed on the company's web site, www.myclyns.com, usingcredit cards or purchase orders. In addition to its own distribution center,MyClyns is also carried by selected premium distributors including Boundtree,Henry Schein/Matrx, Moore Medical, Alliance Medical and Tri-Anim. Customersmay also click directly from the MyClyns site to these distributors. TheMyClyns customer service center can be reached at 877-Go-Clyns (877-462-5967)and is open from 8 AM to 7 PM Eastern Standard Time. The customer servicecenter will accept orders and can answer product questions. MyClyns isavailable in three unit packs as well as in cases of twenty-four.

In order to further support its customers, Union Springs has hired severalregional product specialists to introduce MyClyns to EMS, fire, police andcorrections institutions across the country. The regional product specialistsprovide users with product information, training and support.

MyClyns contains a fast-acting solution with germ-killing action that issafe to use on all mucous membranes including eyes, ears, nose, mouth and openwounds. The MyClyns convenient pen-like design allows first responders toprotect themselves immediately after exposure to harmful pathogens even whilestill caring for those in emergency situations. Since users can protectthemselves immediately, they lower their risk associated with prolongedexposure when immediate clean-up is not an option. MyClyns is intended foruse by police, fire, military, emergency medical personnel, healthcareproviders, and homeland security personnel.

Independent laboratory tests show that the solution in MyClynsdemonstrates a 99.99% reduction in MRSA and many other germs on contact, and a99.99% reduction in Hepatitis C after thirty seconds. MyClyns has alsodemonstrated virucidal activity against HIV-1 and Herpes Simplex Virus type 1in independent laboratory tests.

"We have had an extremely positive response to MyClyns from EMS, fire,police and corrections personnel and we are excited to begin fulfilling ourinitial orders," said Joel Ivers, President of Union Springs Pharmaceuticals."MyClyns is truly a revolutionary first response protection product which weare happy to make available to the men and women who keep us safe on a dailybasis," he added.

About MyClyns(TM)

MyClyns(TM) is the only convenient (pen-like device), non-alcohol, firstresponse spray providing immediate personal protection against a potentiallyharmful exposure that is safe to use on your eyes, ears, mouth, and nose.MyClyns contains a fast-acting solution with germ-killing action that is safeto use on all mucous membranes. Independent laboratory tests show that thesolution in MyClyns demonstrates a 99.99% reduction in MRSA and many othergerms on contact, and a 99.99% reduction in Hepatitis C after thirty seconds.MyClyns has also demonstrated virucidal activity against HIV-1 and HerpesSimplex Virus type 1 in independent laboratory tests. MyClyns protectspersonnel immediately after exposure to harmful pathogens allowing them tocontinue to attend to the situation at hand. Visit the MyClyns website atwww.myclyns.com for more information.

About Union Springs Pharmaceuticals, LLC

Union Springs Pharmaceuticals, LLC (USP) specializes in providinginnovative products for the consumer and healthcare markets. USP licenses,acquires, develops, and commercializes innovative products and technologiesthat satisfy the unmet needs of healthcare professionals and consumers. UnionSprings
Advertisement


Advertisement

You May Also Like

Advertisement
View All

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
User Avatar
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions
s
NeoStrata Research Validates Anti-Aging Benefits o...
S
Two Studies Cast Further Doubt on the Effectivenes...